Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Puccetti

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Recent Patents on Cardiovascular Drug Discovery|January 29, 2008
Pharmacogenetics of statins therapyLuca Puccetti, Maurizio Acampa, Alberto Auteri
Cardiovascular & Hematological Disorders Drug Targets|April 25, 2012
Role of genetic factors in statins side-effectsFrancesca Scarpini, Roberta Cappellone, Alberto Auteri, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activatorsClaudia Temperini, Andrea Scozzafava, Luca Puccetti, et al.
Current Drug Targets. Cardiovascular & Haematological Disorders|April 28, 2005
Mechanisms for antiplatelet action of statinsLuca Puccetti, Anna Laura Pasqui, Alberto Auteri, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamidesOzen Ozensoy, Luca Puccetti, Giuseppe Fasolis, et al.
International Journal of Cardiology|July 10, 2002
Transmitral and pulmonary venous flow study in elite male runners and young adultsAlberto Palazzuoli, Luca Puccetti, Marcello Pastorelli, et al.
Bioorganic & Medicinal Chemistry|July 12, 2005
Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamidesOzen Ozensoy, Isao Nishimori, Daniela Vullo, et al.
International Journal of Cardiology. Heart & Vasculature|August 9, 2017
Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendanRomina Navarri, Stefano Lunghetti, Matteo Cameli, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2008
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substratesAlessio Innocenti, Andrea Scozzafava, Seppo Parkkila, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Carbonic anhydrase activators: activation of isozyme XIII with amino acids and aminesSeppo Parkkila, Daniela Vullo, Luca Puccetti, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Recent Patents on Cardiovascular Drug Discovery|January 29, 2008
Pharmacogenetics of statins therapyLuca Puccetti, Maurizio Acampa, Alberto Auteri
Cardiovascular & Hematological Disorders Drug Targets|April 25, 2012
Role of genetic factors in statins side-effectsFrancesca Scarpini, Roberta Cappellone, Alberto Auteri, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activatorsClaudia Temperini, Andrea Scozzafava, Luca Puccetti, et al.
Current Drug Targets. Cardiovascular & Haematological Disorders|April 28, 2005
Mechanisms for antiplatelet action of statinsLuca Puccetti, Anna Laura Pasqui, Alberto Auteri, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamidesOzen Ozensoy, Luca Puccetti, Giuseppe Fasolis, et al.
International Journal of Cardiology|July 10, 2002
Transmitral and pulmonary venous flow study in elite male runners and young adultsAlberto Palazzuoli, Luca Puccetti, Marcello Pastorelli, et al.
Bioorganic & Medicinal Chemistry|July 12, 2005
Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamidesOzen Ozensoy, Isao Nishimori, Daniela Vullo, et al.
International Journal of Cardiology. Heart & Vasculature|August 9, 2017
Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendanRomina Navarri, Stefano Lunghetti, Matteo Cameli, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2008
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substratesAlessio Innocenti, Andrea Scozzafava, Seppo Parkkila, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Carbonic anhydrase activators: activation of isozyme XIII with amino acids and aminesSeppo Parkkila, Daniela Vullo, Luca Puccetti, et al.
Pageof 5